Home > Press > HORIBA Medical and CEA-Leti Strengthen Their Partnership to Develop Tomorrow’s Diagnostics at the Point of Care
![]() |
Abstract:
HORIBA Medical, a subsidiary of Japan-based HORIBA Group, the global leader for measurement and analysis systems, has been designing, manufacturing and marketing high performance analyzers for laboratories and hospitals for over 30 years. This expertise that has made the company one of the world leaders in Hematology and a key player in the Hemostasis and Clinical Chemistry activity.
Today, patient care and treatment practices are evolving quickly. HORIBA Medical is designing solutions to anticipate patient-centered needs by developing new POCT (Point of Care Testing) systems.
In parallel, for the past six years HORIBA Medical has been working with one of the most innovative organizations in the field of new technologies, CEA-Leti, the technology research laboratory of CEA Tech, federating their respective skills in a Joint Laboratory called HEMACOUNT.
“We focused on two disruptive technologies: a microfluidic cartridge and a new, lens-free imaging device (LensFree), which will enable development of more compact, easier-to-use POCT-type devices,” says Damien Isebe, who heads up this highly innovative project at HORIBA Medical. “Twelve families of patents have been filed since the start of the project, and the latest one has been the subject of several scientific papers”.
“Flow cytometry is the main analytical technology in hematology, but it requires large and complex hardware systems. Conversely, lens-free imaging combined with a sample prepared as a microfluidic cartridge paves the way to a simple and compact disruptive architecture. This imaging technique provides a wide field of view (≈30mm˛) resulting in a counting statistic (a few thousand cells) in one single acquisition consistent with required hematological performance,” explains Sophie Morales, laboratory head at CEA-Leti.
The latest publications and presentations to date: for LensFree, one publication in the Journal of Biomedical Optics and two oral presentations at ECBO (European Conferences on Biomedical Optics), held in Munich in late June 2019; and for the work on microfluidics, presentation of a scientific poster at µTAS (International Conference on Miniaturized Systems for Chemistry and Life Sciences) in Basel, Switzerland, in October 2019.
Given the success of the partnership and the work that remains to be done, HORIBA Medical is pleased to announce the continuation of this collaboration, which will allow it to draw value from this work in the form of innovative applications, to bring developments to maturity and to design products that will serve care-givers and patients.
Patents: DD17052- FR1663028: “Procedure for counting particles in a sample by lens-free imaging”
####
About Leti
Leti, a technology research institute at CEA, is a global leader in miniaturization technologies enabling smart, energy-efficient and secure solutions for industry. Founded in 1967, CEA-Leti pioneers micro-& nanotechnologies, tailoring differentiating applicative solutions for global companies, SMEs and startups. CEA-Leti tackles critical challenges in healthcare, energy and digital migration. From sensors to data processing and computing solutions, CEA-Leti’s multidisciplinary teams deliver solid expertise, leveraging world-class pre-industrialization facilities. With a staff of more than 1,900, a portfolio of 3,100 patents, 10,000 sq. meters of cleanroom space and a clear IP policy, the institute is based in Grenoble, France, and has offices in Silicon Valley and Tokyo. CEA-Leti has launched 65 startups and is a member of the Carnot Institutes network. Follow us on www.leti-cea.com and @CEA_Leti.
About HORIBA Medical
HORIBA Medical offers an extensive and comprehensive line of hematology, coagulation and clinical chemistry solutions (including reagents) for in vitro diagnostics. The HORIBA Medical brand has earned the trust of a wide customer base through the quality and reliability of its products. Today, over 30,000 laboratories around the world use HORIBA Medical solution (more information at: www.horiba.com).
For more information, please click here
Contacts:
Press Contact HORIBA Medical
Carole Barascud
Public and Media Relations
Tel. +33.4.67.14.15.59
Press Contact CEA-Leti
Agency
Tel. +33 6 74 93 23 47
Copyright © Leti
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Optical switching at record speeds opens door for ultrafast, light-based electronics and computers: March 24th, 2023
Robot caterpillar demonstrates new approach to locomotion for soft robotics March 24th, 2023
Semiconductor lattice marries electrons and magnetic moments March 24th, 2023
Light meets deep learning: computing fast enough for next-gen AI March 24th, 2023
Chemistry
Recent progress of carbon-based non-noble metal single-atom catalysts for energy conversion electrocatalysis March 3rd, 2023
Scientists push the boundaries of manipulating light at the submicroscopic level March 3rd, 2023
Dual-site collaboration boosts electrochemical nitrogen reduction on Ru-S-C single-atom catalyst January 6th, 2023
Imaging
Novel microscope developed to design better high-performance batteries: Innovation gives researchers inside view of how batteries work February 10th, 2023
Possible Futures
New experiment translates quantum information between technologies in an important step for the quantum internet March 24th, 2023
Graphene grows – and we can see it March 24th, 2023
HKUMed invents a novel two-dimensional (2D) ultrasound-responsive antibacterial nano-sheets to effectively address bone tissue infection March 24th, 2023
A universal HCl-assistant powder-to-powder strategy for preparing lead-free perovskites March 24th, 2023
Nanomedicine
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Scientists push the boundaries of manipulating light at the submicroscopic level March 3rd, 2023
Discoveries
New experiment translates quantum information between technologies in an important step for the quantum internet March 24th, 2023
Graphene grows – and we can see it March 24th, 2023
HKUMed invents a novel two-dimensional (2D) ultrasound-responsive antibacterial nano-sheets to effectively address bone tissue infection March 24th, 2023
A universal HCl-assistant powder-to-powder strategy for preparing lead-free perovskites March 24th, 2023
Announcements
Robot caterpillar demonstrates new approach to locomotion for soft robotics March 24th, 2023
Semiconductor lattice marries electrons and magnetic moments March 24th, 2023
Light meets deep learning: computing fast enough for next-gen AI March 24th, 2023
Bilayer PET/PVDF substrate-reinforced solid polymer electrolyte improves solid-state lithium metal battery performance March 24th, 2023
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
Nanobiotechnology
HKUMed invents a novel two-dimensional (2D) ultrasound-responsive antibacterial nano-sheets to effectively address bone tissue infection March 24th, 2023
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Scientists push the boundaries of manipulating light at the submicroscopic level March 3rd, 2023
Research partnerships
Polymer p-doping improves perovskite solar cell stability January 20th, 2023
New insights into energy loss open doors for one up-and-coming solar tech November 18th, 2022
![]() |
||
![]() |
||
The latest news from around the world, FREE | ||
![]() |
![]() |
||
Premium Products | ||
![]() |
||
Only the news you want to read!
Learn More |
||
![]() |
||
Full-service, expert consulting
Learn More |
||
![]() |